DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Maturation inhibitor
Maturation inhibitor
Download Article PDF/Slides
Tim Horn Deputy Executive Director, HIV & HCV Programs Treatment
Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
14-258 Phrma HIV/AIDS2014 0819.Indd
Download Article PDF/Slides
What's in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV And
Can the Further Clinical Development of Bevirimat Be Justified?
Antiviral Activity Exerted by Natural Products Against Human Viruses
Treatmen+ (E) HTB: 2019 Vol 20 No 4 Bulletin
C07K 16/10 (2006.01) Foster City, California 94404 (US)
Peltophorum Africanum, a Traditional South African Medicinal Plant, Contains an Anti HIV-1 Constituent, Betulinic Acid
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
Development of a Binding Assay Between the HIV-1 Envelope
HIV Pipeline 2017: Targets in the HIV Lifecycle Targets in the HIV Lifecycle 1 HIV Attaches to a CD4 Cell
HIV-1 Maturation: Lessons Learned from Inhibitors
HIV Drugs 18/1/06 09:33 Page 44
TABLE 2. HIV Treatment Pipeline 2003–2012 Class Drug Name Generic Name Brand Name Sponsor 2003 2004 2005 2006 2007 2008 2009 2
Entry Inhibitors
Top View
Aids 20072007 What Is New
Novel Antiretroviral Agents
Chemical Diversity and Activity Profiles of HIV-1 Reverse Transcriptase
NIH Public Access Author Manuscript Med Res Rev
Review Article Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its ‡ Derivatives
Crystalline Form of Cabotegravir Sodium Krystalline Form Von Cabotegravir Natriumsalz Forme Cristalline Du Sel De Sodium De Cabotegravir
Clinical Protocol AI468048
HIV 102:Care & Treatment
Insight Into the Mechanism of Action of EP-39, A
Antiretroviral and Directly Acting Antiviral Drug Metabolism and Transporter Characteristics (Summary)
Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
2004 Antiretrovirals Pipeline Report
COVID-19: Preventing Future Pandemics Copyright © 2020 Kostoff, Briggs, and Porter
Viiv Healthcare Meet the Management Viiv Healthcare Meet the Management
Human Immunodeficiency Virus
The Outlook for a Cure There Is a Formidable Arsenal of Drugs Available to Treat HIV
Anti-Retroviral Drugs for HIV: Old and New
The Antiretroviral Pipeline
The Structural Biology of HIV-1: Mechanistic and Therapeutic Insights
Recent Developments in HIV Treatment and Their Dissemination in Poor
New Drugs and Formulations: Effect on Therapeutic Paradigms
Plant-Derived Leading Compounds for Chemotherapy of Human Immunodefiency Virus (HIV) Infection – an Update (1998 –2007)
HIV Pipeline2020 New Drugs in Development Htb Supplement: 2020 Vol 21:(1)
Antiretroviral Therapy PIPELINE REPORT 2019
(12) Patent Application Publication (10) Pub. No.: US 2008/0241289 A1 Gant Et Al
Antiretroviral and Directly Acting Antiviral Drug Metabolism and Transporter Characteristics (Summary)
Novel Prospective Treatment Options
2011 Pipeline Report Second Edition
2- Dyson-2018 New Therapies Presentation
Medicines in Development ꟷ Infectious Diseases
120 Region of HIV-1 Env, Especially in the V2 and V3 Regions – Switching Co-Receptor Usage • CCR5 CXCR4